Auxilium Pharmaceuticals Inc

Type: Company
Name: Auxilium Pharmaceuticals Inc
Nationality: United States
Web Address: http://www.auxilium.com/
First reported 19 hours ago - Updated 19 hours ago - 1 reports

Best Relative Performance in the Pharmaceuticals Industry Detected in Shares of Auxilium Pharmaceuticals (AUXL, FLML, AKRX, DEPO, VVUS)

Written on Thu, 04/17/2014 - 9:01amBy Shiri GuptaBelow are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have ... [Published Comtex SmarTrend - 19 hours ago]
First reported Apr 10 2014 - Updated Apr 11 2014 - 1 reports

Auxilium Pharmaceuticals Shares Sinking Lower, Down 2.2%

Auxilium Pharmaceuticals (NASDAQ:AUXL), a company whose shares are moving quickly, is trading 2.2% lower to $26.59. The Dow is down 0.2% to 16,399 and the S&P is currently down 0.4% to 1,864. ... [Published Individual.com - Apr 10 2014]
First reported Apr 09 2014 - Updated Apr 09 2014 - 1 reports

Auxilium Pharmaceuticals Receives Consensus Recommendation of “Buy” from Brokerages (NASDAQ:AUXL)

Shares of Auxilium Pharmaceuticals (NASDAQ:AUXL) have earned a consensus recommendation of "Buy" from the fifteen brokerages that are currently covering the stock, . One analyst has rated the stock with a sell recommendation, two have given a hold recommendation ... [Published American Banking News - Apr 09 2014]
First reported Apr 07 2014 - Updated Apr 08 2014 - 1 reports

AUXILIUM PHARMACEUTICALS : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

(4-traders.com)Item 7.01 Regulation FD Disclosure.On April 7, 2014, Swedish Orphan Biovitrum AB (publ) (Sobi) and AuxiliumPharmaceuticals, Inc. (NASDAQ: AUXL) announced that Sobi became the MarketAuthorisation Holder (MAH) for Xiapex® (collagenase ... [Published 4 Traders - Apr 07 2014]
First reported Apr 07 2014 - Updated Apr 07 2014 - 3 reports

Swedish Orphan Biovitrum Becomes Market Authorisation Holder For Xiapex In Europe

-- Swedish Orphan Biovitrum AB (publ) (Sobi) and Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) today announced that Sobi became the Market Authorisation Holder (MAH) for Xiapex® (collagenase clostridium histolyticum), in 28 EU member countries, Norway, ... [Published BioSpace - Apr 07 2014]
First reported Apr 03 2014 - Updated Apr 03 2014 - 1 reports

Shares of Auxilium Pharmaceuticals Under Pressure, Down 1.1%

One of today's stocks on the move is Auxilium Pharmaceuticals (NASDAQ:AUXL), down 1.1% to $27.95. The Dow Jones Industrial Average is now trading fractionally lower to 16,563 and the S&P is trading fractionally lower to 1,89 ... [Published Individual.com - Apr 03 2014]
First reported Mar 27 2014 - Updated Mar 27 2014 - 1 reports

Erectile Dysfunction Drugmaker Takes on Viagra

A Chester County biopharmaceutical company is hoping to score customers for its new erectile dysfunction drug by pitching the product to college basketball fans during the NCAA men’s basketball tournament.Auxilium Pharmaceuticals is launching an ad campaign ... [Published NBC Philadelphia - Mar 27 2014]
First reported Mar 27 2014 - Updated Mar 27 2014 - 1 reports

Buyers Accumulate Shares of Auxilium Pharmaceuticals, Up 1.3%

One of today's notable stocks on the rise is Auxilium Pharmaceuticals (NASDAQ:AUXL), up 1.3% to $27.62. The Dow is trading fractionally higher to 16,289 and the S&P is currently trading fractionally higher to 1,853. ... [Published Individual.com - Mar 27 2014]
First reported Mar 25 2014 - Updated Mar 25 2014 - 1 reports

Apricus Biosciences names new vice president of business development

Apricus Biosciences, Inc., a developer of novel therapeutics for men's and women's health, has announced the appointment of Neil Morton as the new vice president of business development. Mr Morton brings to Apricus a successful track record in business ... [Published Individual.com - Mar 25 2014]
First reported Mar 21 2014 - Updated Mar 21 2014 - 1 reports

RBC Capital Increases Auxilium Pharmaceuticals Price Target to $36.00 (AUXL)

Stock analysts at RBC Capital upped their price objective on shares of Auxilium Pharmaceuticals (NASDAQ:AUXL)In other Auxilium Pharmaceuticals news, EVP Tito Benjamin Del, Jr. sold 32,032 shares of the stock in a transaction dated Friday, March 14th. ... [Published American Banking News - Stock Ratings - Mar 21 2014]
First reported Mar 20 2014 - Updated Mar 20 2014 - 2 reports

Apricus Biosciences Expands Senior Management Team, Appointing As Vice President, Business Development

(GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a pharmaceutical company focusing on the development and commercialization of novel therapeutics for men's and women's health, today announced the appointment of Neil C. Morton as Vice President ... [Published BioSpace - Mar 20 2014]
First reported Mar 17 2014 - Updated Mar 17 2014 - 2 reports

Auxilium Pharmaceuticals : To Ring the NASDAQ Stock Market Opening Bell On February 26, 2014

CHESTERBROOK, Pa., Feb. 19, 2014 /PRNewswire/ --  Auxilium Pharmaceuticals , Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, will ring the Opening Bell at the NASDAQ MarketSite in Times Square, New York at 9:30 a.m. ET on ... [Published 4 Traders - Mar 17 2014]

Quotes

Title: "Use of Avanafil and Successful Intercourse Within Approximately 15 Minutes of Dosing in Men With Mild to Severe Erectile Dysfunction"
...First Manhattan's central complaint was that "The sitting board and CEO committed the fatal flaw of failing to secure a pre-launch large pharma commercial partner for Qsymia. Securing a commercial partner is a decision that did not require much "business savvy." In fact, it just required a bit of common sense since no small company has ever successfully launched a blockbuster drug into the primary care market. Both of our obesity competitors, Arena and Orexigen, got it right on the commercial partnership, but Vivus' sitting board and CEO got it wrong."
"We are excited to announce the addition of Neil Morton, whose accomplishments in life sciences business development will be key as we seek to fully leverage the potential of our lead product Vitaros, out-license ex-US Femprox rights, and build a robust pipeline of innovative products in men's and women's health" said Mr Pascoe
Mr. Morton stated, "I am thrilled to become part of Apricus' management team during this important time for the Company, as Vitaros® is expected to launch throughout 2014 and the Company's earlier product pipeline continues to advance. I am looking forward to making significant contributions towards building Apricus' presence in the areas of men's and women's health."

More Content

All (83) | News (62) | Reports (0) | Blogs (10) | Audio/Video (0) | Fact Sheets (0) | Press Releases (10)
sort by: Date | Relevance
Best Relative Performance in the Pharmaceutical... [Published Comtex SmarTrend - 19 hours ago]
Auxilium, Sobi present data from clinical trial... [Published PharmaBiz - Apr 15 2014]
Testosterone Treatment Lawsuit Alleges Testim C... [Published PRWeb - Apr 14 2014]
Hottest Healthcare Stocks Now – EW HTWR BSX LGND [Published InvestorPlace.com - Apr 14 2014]
Shares of AUXL Down 11.9% Since Downtrend Call ... [Published Individual.com - Apr 14 2014]
Auxilium and Sobi Announce Encore Presentation ... [Published PR Newswire: General Business - Apr 14 2014]
VIVUS : Avanafil Clinical Data to Be Presented ... [Published 4 Traders - Apr 11 2014]
Certifications, Authorizations, Stock Updates, ... [Published Financial Services - Apr 10 2014]
Auxilium Pharmaceuticals Shares Sinking Lower, ... [Published Individual.com - Apr 10 2014]
Sobi becomes MAH for Auxilium's Dupuytren's con... [Published Individual.com - Apr 09 2014]
Auxilium Pharmaceuticals Receives Consensus Rec... [Published American Banking News - Apr 09 2014]
Swedish Orphan Biovitrum Becomes Market Authori... [Published BioSpace - Apr 07 2014]
Sobi announced as Market Authorisation Holder f... [Published Individual.com - Apr 07 2014]
AUXILIUM PHARMACEUTICALS : Regulation FD Disclo... [Published 4 Traders - Apr 07 2014]
Sobi Becomes Market Authorisation Holder For Xi... [Published PR Newswire: General Business - Apr 07 2014]
Sobi becomes market authorisation holder for Xi... [Published NASDAQ OMX - Apr 07 2014]
Sobi becomes market authorisation holder for Xi... [Published GlobeNewswire: Advertising News - Apr 07 2014]
Shares of Auxilium Pharmaceuticals Under Pressu... [Published Individual.com - Apr 03 2014]
BioSpecifics Technologies Corp. to Present at t... [Published Benzinga.com - Apr 02 2014]
BioSpecifics Technologies Corp. to Present at t... [Published TickerTech.com - Apr 02 2014]
Biggest Movers in Healthcare Stocks Now – ISRG ... [Published InvestorPlace.com - Apr 01 2014]
James Flynn, Deerfield Management Step Up Inter... [Published InsiderMonkey.com - Mar 31 2014]
Biggest Movers in Healthcare Stocks Now – MNKD ... [Published InvestorPlace.com - Mar 28 2014]
Biggest Movers in Healthcare Stocks Now – EXAS ... [Published InvestorPlace.com - Mar 27 2014]
Buyers Accumulate Shares of Auxilium Pharmaceut... [Published Individual.com - Mar 27 2014]
Erectile Dysfunction Drugmaker Takes on Viagra [Published NBC Philadelphia - Mar 27 2014]
Vivus: Shares Are Oversold, Pressure Is On To S... [Published Seeking Alpha - Mar 26 2014]
Testosterone Lawsuit News: Second Testim User F... [Published PRWeb - Mar 25 2014]
Apricus Biosciences names new vice president of... [Published Individual.com - Mar 25 2014]
Top Analysts Action: EMR, SYMC, EQY, VOLC, CLGX [Published BayStreet.ca - Mar 21 2014]
1 2 3
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Auxilium and Sobi Announce Encore Presentation ... [Published PR Newswire: General Business - Apr 14 2014]
CHESTERBROOK, Pa. and STOCKHOLM, April 14, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) and Swedish Orphan Biovitrum AB (publ) (Sobi) today announced that encore data were presented from multiple clinical trials evaluating the use ...
Sobi Becomes Market Authorisation Holder For Xi... [Published PR Newswire: General Business - Apr 07 2014]
STOCKHOLM and CHESTERBROOK, Pa., April 7, 2014 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi) and Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) today announced  that Sobi became the Market Authorisation Holder (MAH) for Xiapex® (collagenase ...
Auxilium Pharmaceuticals, Inc. To Present At Th... [Published PR Newswire: Health - Mar 04 2014]
CHESTERBROOK, Pa., March 4, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced that certain members of the executive management team will participate in the Barclay's ...
Auxilium Pharmaceuticals, Inc. To Present At Th... [Published PR Newswire: General Business - Feb 25 2014]
CHESTERBROOK, Pa., Feb. 25, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced that certain members of the executive management team will participate in the Cowen ...
Auxilium Pharmaceuticals, Inc. Announces The FD... [Published PR Newswire: Health - Feb 24 2014]
CHESTERBROOK, Pa., Feb. 24, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted the Company's submission ...
1 2

Press Releases

sort by: Date | Relevance
Certifications, Authorizations, Stock Updates, ... [Published Financial Services - Apr 10 2014]
Sobi becomes market authorisation holder for Xi... [Published GlobeNewswire: Advertising News - Apr 07 2014]
Auxilium Pharmaceuticals Announces Fourth Quart... [Published Financial Services - Feb 28 2014]
Auxilium Pharmaceuticals, Inc. [AUXL] to Ring T... [Published GlobeNewswire: Acquisitions News - Feb 25 2014]
Auxilium Pharmaceuticals, Inc. To Announce Four... [Published Financial Services - Feb 21 2014]
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.